Johannes A Bogaards

Summary

Affiliation: VU University Medical Center
Country: The Netherlands

Publications

  1. ncbi Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models
    Johannes A Bogaards
    Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
    PLoS Med 8:e1001147. 2011
  2. ncbi Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus
    Johannes A Bogaards
    Department of Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands
    Am J Epidemiol 171:817-25. 2010
  3. ncbi Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence
    Johannes A Bogaards
    Department of Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands
    Epidemiology 22:505-15. 2011
  4. ncbi The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands
    Johannes A Bogaards
    Department of Epidemiology and Biostatistics, VU University Medical Centre, P O Box 7057, 1007 MB Amsterdam, The Netherlands
    Vaccine 29:8929-36. 2011
  5. ncbi Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening
    Veerle M H Coupé
    Department of Epidemiology and Biostatistics, VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Vaccine 30:1813-22. 2012
  6. ncbi Enrichment broth improved detection of extended-spectrum-beta-lactamase-producing bacteria in throat and rectal surveillance cultures of samples from patients in intensive care units
    Jean Luc A N Murk
    VU University Medical Center, Medical Microbiology and Infection Control, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    J Clin Microbiol 47:1885-7. 2009
  7. ncbi The health and economic effects of HPV DNA screening in The Netherlands
    Johannes Berkhof
    Department of Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands
    Int J Cancer 127:2147-58. 2010

Collaborators

Detail Information

Publications7

  1. ncbi Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models
    Johannes A Bogaards
    Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
    PLoS Med 8:e1001147. 2011
    ..Here, we address the question of whether vaccinating females only, males only, or both sexes is the most effective strategy to reduce the population prevalence of an STI like HPV...
  2. ncbi Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus
    Johannes A Bogaards
    Department of Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands
    Am J Epidemiol 171:817-25. 2010
    ..Because high transmission potential is associated with a low impact of herd immunity, extensive vaccination coverage will be required to substantially reduce cervical cancer incidence...
  3. ncbi Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence
    Johannes A Bogaards
    Department of Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands
    Epidemiology 22:505-15. 2011
    ..We attempt to disentangle the direct and indirect effects of HPV vaccination, while accounting for 14 oncogenic HPV types in a dynamic modeling framework...
  4. ncbi The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands
    Johannes A Bogaards
    Department of Epidemiology and Biostatistics, VU University Medical Centre, P O Box 7057, 1007 MB Amsterdam, The Netherlands
    Vaccine 29:8929-36. 2011
    ..We calculated the clinical benefit and cost-effectiveness of vaccinating women aged 17-25 years in 2010...
  5. ncbi Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening
    Veerle M H Coupé
    Department of Epidemiology and Biostatistics, VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands
    Vaccine 30:1813-22. 2012
    ..One screen during lifetime remains cost-effective in addition to broad spectrum vaccination offering protection against many high-risk HPV types...
  6. ncbi Enrichment broth improved detection of extended-spectrum-beta-lactamase-producing bacteria in throat and rectal surveillance cultures of samples from patients in intensive care units
    Jean Luc A N Murk
    VU University Medical Center, Medical Microbiology and Infection Control, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    J Clin Microbiol 47:1885-7. 2009
    ..Preenrichment of throat and rectal swabs in TSB prior to inoculation on solid medium doubled the number of ESBL(+) bacteria detected in samples obtained from patients in our intensive care unit...
  7. ncbi The health and economic effects of HPV DNA screening in The Netherlands
    Johannes Berkhof
    Department of Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands
    Int J Cancer 127:2147-58. 2010
    ..Our model indicates that HPV testing with cytology triage is likely to be cost effective. An extension of the screening interval may be considered to control costs...